ATORVALIQ
Peakatorvaliq
NDAORALSUSPENSION
Approved
Feb 2023
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol. In animal models, atorvastatin lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA…
Indications (2)
Loss of Exclusivity
LOE Date
Jun 7, 2037
137 months away
Patent Expiry
Jun 7, 2037